TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES
description
Transcript of TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES
![Page 1: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/1.jpg)
TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL
ACTIVITIES
![Page 2: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/2.jpg)
Dr. M. Nazrul Islam Siddiqui
FCPS, MD
Associate Professor of Endocrinology
Mymensingh Medical College & Hospital
• .
![Page 3: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/3.jpg)
Ethical principles
• “The health of my patient will be my first consideration”.
• “A physician shall act only in the patient’s interest…..”.
![Page 4: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/4.jpg)
Guidelines• Nuremberg code: 1947
• Helsinki declaration : WMA 1964,1975,1983,1989,1996,2000
• Belmont report : 1979
• International ethical guidelines:
CIOMS – 1982,1993,2002.
![Page 5: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/5.jpg)
Guidelines (Cont..) • Guidelines for good clinical practice
for trials on pharmaceutical products: WHO – 1995
• Universal Declaration on Human Genome & Human Rights: UNESCO – 1997
• Operational Guidelines: WHO – 2000
• Surveying & Evaluating Ethical Review Practice: WHO – 2002.
![Page 6: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/6.jpg)
Islam & Ethical Principles
Basic life support • Organ transplantation
• Reproductive health
• Genetics
• etc. –Needs application of basic
principles of Islam
![Page 7: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/7.jpg)
Islam & Ethical Principles
“and he makes for them good things lawful & bad things forbidden” – –Surah no.7, Ayet no. 157.
![Page 8: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/8.jpg)
Animal Experiment & Ethics
• Medical research
• Laboratory animals
• Proper handling
• Rationality of animal experiment
• IRB
• AEEC
![Page 9: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/9.jpg)
Ethical Issues
Important Fields• Ethics in health care
• Ethics in medical education
• Ethics in health administration
• Ethics in health research
• etc.
![Page 10: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/10.jpg)
Ethical Review Committee (ERC)
• BMRC ERC NCE
• Each & every project SRC ethical clearance
• ERC provides clearance for: – BMRC funded research projects
– Project founded by organizations
– Research studies leading to postgraduate degrees.
![Page 11: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/11.jpg)
Ethical Clearance
Categories of research/ studies • Survey
• Research studies involving invasive methods, trials, experiments etc.
• Policy Issues
![Page 12: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/12.jpg)
Ethical Clearance
APPLICATION FORM1. Principal Investigator (s)
2. Co- Investigators
3. Place of study/ Institution
4. Title of study
![Page 13: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/13.jpg)
ECApplication form (cont..)
5. Type of study
6. Duration
7. Total cost
8. Funding Agency
![Page 14: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/14.jpg)
EC
Application form1. Source of population:
(a) Ill subjects Yes No
(b)Non Ill subjects Yes No
(c)Minors or persons Yes No
under guardianship
![Page 15: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/15.jpg)
EC
Application form(cont)..
2. Does the study involve: a. Physical risks to the subject Yes No
b. Social risks Yes
No
c. Psychological risks Yes No
d. Discomfort to subjects Yes No
![Page 16: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/16.jpg)
EC
Application form (cont..)
2. e. Invasion of the body Yes No
f. Invasion of privacy Yes No
g. Disclosure of information Yes No
damaging to subject or others
![Page 17: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/17.jpg)
EC
Application form (cont..) 3. Does the study involve:
(a)Use of records Yes No
(hospital, medical,
death, birth or other)
(b) Use of fetal tissues Yes No
or abortus
(c) Use of organs or Yes No
body fluids
![Page 18: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/18.jpg)
EC
Application form (cont..)
4. Are subjects clearly informed about:
(a) Nature and purposes of study Yes No
(b) Procedures to be followed Yes No
including alternatives used
c) Physical risks Yes No
(d) Private questions Yes No
(e) Invasion of the body Yes No
![Page 19: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/19.jpg)
EC
4. Application form (cont..) f) Benefits to be derived Yes No
g) Right to refuse to participate Yes No
or to withdraw from study
h) Confidential handling of data Yes No
i) Compensation where there are Yes No
risks or loss of working time or
privacy is involved in any
particular procedure
![Page 20: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/20.jpg)
ECApplication form (cont..)5. Will sign consent form/verbal
consent be required: (a) From subjects Yes No (b) From parent or guardian Yes No
(if subjects are minors) 6. Will precautions be Yes No
taken to protect anonymity
of subjects
![Page 21: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/21.jpg)
ERC
ABSTRACT:
• Abstracts/ summary: is essential
• Purpose of the study
• Methods
• Procedure
![Page 22: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/22.jpg)
Abstract/ Summary Points to be illustrated:
1. Rationale of using a special group .
2. Potential risks: physical, psychological, social, legal etc.
3. Protection against risks.
4. Safeguarding confidentiality
![Page 23: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/23.jpg)
Abstract/ summary (cont..)5. When potential risks/Question of
privacy needs signed informed consent:
(a) If signed consent will not be taken – why ?
Provide altenative procedure e.g – verbal.
(b) If information is withheld – justify.
( c) In case of potential risks/ loss of work time – cpmpensation
![Page 24: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/24.jpg)
Abstract/ summary (cont..)
6. If study involves interview: time. place & context
7. Benefits to the subjects, society & favorable risk – benefit ratio.
8. If experimental drugs: status of registration in BD & developed countries
9. Experimental ‘new drugs’ : toxicity studies should be annexed.
![Page 25: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/25.jpg)
Abstract/ summary (cont..)
10. If placebo is used: justify
11. If experimental ‘new drug’: sponsorship & its conditions
12. Use of records: hospital, medical, birth, death etc.
Other materials: organs, tissues, body fluids, fetus, abortus etc.
![Page 26: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/26.jpg)
ERC Check documents: Umbrella proposal Proposal summary Abstract for ethical Review committee as per
attachment (Obligatory) Informed consent form for subjects Informed consent form for parent or guardian Verbal consent form for subject Procedure for maintaining confidentiality Questionnaire or interview schedule
![Page 27: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/27.jpg)
MMC
Institutional Ethical Activities• Ethical Review Committee:
– Operational guidelines, WHO,2000– BMRC
• Clause no. 4.1: – Academic council – Consensus of the members – Rotation of membership
![Page 28: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/28.jpg)
IEA (cont..) Clause no. 4.2:
– Duration of appointments: at least 1 yr.
– Renewal of appointment
– In case of resign or transfer
Clause no. 4.4: – Clearly defined office
– Adequate staff support
![Page 29: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/29.jpg)
IEA (cont..)
Number of members: at least 7 – 9.
–One chairman
–One member secretary
• Quorum: By simple majority
![Page 30: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/30.jpg)
Ethical Review Committee• Decision in the Academic Council:
29 January 2006
• Ethical Review Committee was formed
Structure: 11 members
• Chairman: Prof. Dr. Nurul Islam
• Member secretary: Dr. Feroza Parveen
MMCMMC
![Page 31: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/31.jpg)
MMC ERC Members:1. Prof. Dr. Saiyeedur Rahman
2. Prof. Dr. Md. Akram Hossain
3. Prof. Majahed Uddin Ahamed
4. Prof. Dr. Md. Anwar Hossain
5. Prof. Dr. Md. Manirul Islam
6. Dr. Kamrun Nahar
7. Dr. Md. Azizul Haque
8. Dr. Md. Nazrul Islam Siddiqui
9. Dr. U.K. Taufiqun Nessa
![Page 32: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/32.jpg)
MMC
ERC • First meeting: 30 March 2006
• Resolutions: – To form scientific review committee
– Thesis protocol: Needs Ethical clearance
– Seminar on: Ethics in Medical Research
![Page 33: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/33.jpg)
SUMMARY • Biomedical research is the key of
development
• Research should be problem based with favourable risk benefit ratio
• Ethical research leads to a healthy out come
• All research activities should be conducted by ethical guidelines
• All research activities must have clearance from ERC.
![Page 34: TITLE: ETHICAL CLEARANCE & INSTITUTIONAL ETHICAL ACTIVITIES](https://reader033.fdocuments.in/reader033/viewer/2022061513/56815167550346895dbf959b/html5/thumbnails/34.jpg)